第一種能夠?yàn)閷?shí)驗(yàn)室信息系統(tǒng)(LIS)提供連通性的血細(xì)胞計(jì)數(shù)系統(tǒng)，綜合了Beckman Coulter(Fullerton, CA, USA)公司的FC 500流式細(xì)胞儀和該公司的新型FP 1000樣本處理系統(tǒng)。

這套系統(tǒng)為高通量臨床參考實(shí)驗(yàn)室而設(shè)計(jì)，綜合細(xì)胞計(jì)數(shù)解決方案(ICS)的流線型工作流程和整個(gè)測(cè)試全程跟蹤樣本--從收到樣本和準(zhǔn)備，到數(shù)據(jù)獲取和分析，以及出具報(bào)告。這可以幫助實(shí)驗(yàn)室對(duì)細(xì)胞計(jì)數(shù)檢測(cè)過程進(jìn)行標(biāo)準(zhǔn)化，增加效率、精確性和操作者的安全。

流式細(xì)胞儀是一種廣泛應(yīng)用的血細(xì)胞分類自動(dòng)檢測(cè)工具。通常用于體外檢測(cè)鑒別和枚舉疾病指標(biāo)的細(xì)胞亞群，例如艾滋病、白血病和淋巴瘤。這些指標(biāo)能夠幫助監(jiān)測(cè)疾病進(jìn)程和治療效果。

“這種新的解決方案代表了我們公司戰(zhàn)略的核心--將用戶操作過程簡單化和自動(dòng)化，”Beckman Coulter公司翻譯解決方案事務(wù)中心副總裁Bonnie Anderson說，“通過引入完全整合的細(xì)胞計(jì)數(shù)解決方案，我們進(jìn)一步鞏固了我們公司在流式細(xì)胞儀自動(dòng)化領(lǐng)域的領(lǐng)導(dǎo)者地位。”

Cytometry System With LIS Connectivity
 
The first cytometry system to offer laboratory information system (LIS) connectivity combines the FC 500 flow cytometer of Beckman Coulter (Fullerton, CA, USA) with the company’s new FP 1000 sample processing system.

Designed for high-volume clinical reference laboratories, this integrated cytometry solution (ICS) streamlines workflow and tracks samples throughout the testing process--from receipt and preparation, to acquisition and analysis of data, to reporting results. This is an approach that helps laboratories to standardize their flow cytometry testing process, increasing efficiency, accuracy, and operator safety.

Flow cytometry is widely used to provide an automated analysis of blood cell populations. It is commonly used in in vitro diagnostics to identify and enumerate cell populations that are key indicators of diseases, such as HIV, leukemia, and lymphoma. These indicators help monitor disease progression and therapy effectiveness.

“This new solution reflects the essence of our company’s strategy--to simplify and automate customer processes to improve productivity,” said Bonnie Anderson, vice president of Beckman Coulter’s Translational Solutions business center. “Through the introduction of a fully integrated cytometry solution, we are further securing our position as a leader in flow cytometry automation.”